These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18537668)

  • 1. COX-2 inhibition in schizophrenia and major depression.
    Müller N; Schwarz MJ
    Curr Pharm Des; 2008; 14(14):1452-65. PubMed ID: 18537668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
    Müller N
    Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects.
    Müller N; Myint AM; Schwarz MJ
    Curr Pharm Des; 2011; 17(2):130-6. PubMed ID: 21361867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological treatment options for schizophrenia.
    Müller N; Myint AM; Schwarz MJ
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1606-13. PubMed ID: 22283758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers and depression.
    Müller N; Myint AM; Schwarz MJ
    Neurotox Res; 2011 Feb; 19(2):308-18. PubMed ID: 20658274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.
    Muller N; Schwarz M
    Neurotox Res; 2006 Oct; 10(2):131-48. PubMed ID: 17062375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.
    Miüller N; Schwarz MJ
    J Neural Transm Suppl; 2007; (72):269-80. PubMed ID: 17982903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory treatment in schizophrenia.
    Müller N; Myint AM; Krause D; Weidinger E; Schwarz MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():146-53. PubMed ID: 23178230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in schizophrenia.
    Müller N; Myint AM; Schwarz MJ
    Adv Protein Chem Struct Biol; 2012; 88():49-68. PubMed ID: 22814706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment.
    Müller N; Myint AM; Schwarz MJ
    Dialogues Clin Neurosci; 2009; 11(3):319-32. PubMed ID: 19877499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.
    Steiner J; Bogerts B; Sarnyai Z; Walter M; Gos T; Bernstein HG; Myint AM
    World J Biol Psychiatry; 2012 Oct; 13(7):482-92. PubMed ID: 21707463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders.
    Müller N; Schwarz MJ
    Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():97-106. PubMed ID: 18516521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune System and Schizophrenia.
    Müller N; Schwarz MJ
    Curr Immunol Rev; 2010 Aug; 6(3):213-220. PubMed ID: 21057585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of the treatment of depression and schizophrenia.
    Müller N
    Dialogues Clin Neurosci; 2017 Mar; 19(1):55-63. PubMed ID: 28566947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological treatment options for schizophrenia].
    Müller N; Krause D; Weidinger E; Schwarz M
    Fortschr Neurol Psychiatr; 2014 Apr; 82(4):210-9. PubMed ID: 24710677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
    Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC
    Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunology in schizophrenic disorders].
    Müller N; Schwarz MJ
    Nervenarzt; 2007 Mar; 78(3):253-6, 258-60, 262-3. PubMed ID: 16897051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of major depression.
    Müller N
    Neuroimmunomodulation; 2014; 21(2-3):123-30. PubMed ID: 24557045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.